The VitroScan Story
The VitroScan team, collaborating clinicians, and our investors are convinced that major benefit in the care of cancer patients can be achieved by accurate prediction of true responders and non-responders to cancer drugs. We aim to support personalized treatment strategies by identifying effective therapies for patients and in the meantime reduce the toxicity and cost of inefficacious treatments.
Our people are highly motivated experts in life science business, oncology, cell biology, bioinformatics, and clinical trials. The team has a synergistic approach to leverage the value of our technology platform together with stakeholders in the field to progress our development and build a sustainable business.